Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v2-FR
Language French French
Date Updated 2024-05-15 2024-05-15
Drug Identification Number 02182777 02182777
Brand name METHOTREXATE INJECTION USP METHOTREXATE INJECTION USP
Common or Proper name METHOTREXATE INJECTION USP METHOTREXATE INJECTION USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients METHOTREXATE METHOTREXATE
Strength(s) 25MG 25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL
Packaging size 1 X 5 VIALS 1 X 5 VIALS
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2024-08-07 2024-08-07
Actual start date
Estimated end date 2024-08-19 2024-08-19
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments